Age-specific nasal epithelial responses to SARS-CoV-2 infection

Maximillian Woodall(Great Ormond Street Hospital), Ana-Maria Cujba(Wellcome Sanger Institute), Kaylee B. Worlock(University College London), Katie‐Marie Case(Great Ormond Street Hospital), Tereza Masonou(Great Ormond Street Hospital), Masahiro Yoshida(University College London), Krzysztof Polański(Wellcome Sanger Institute), Ni Huang(Wellcome Sanger Institute), Rik G.H. Lindeboom(Wellcome Sanger Institute), Lira Mamanova(Wellcome Sanger Institute), Liam Bolt(Wellcome Sanger Institute), Laura Richardson(Wellcome Sanger Institute), Batuhan Çakır(Wellcome Sanger Institute), Samuel Ellis(Great Ormond Street Hospital), Machaela Palor(Great Ormond Street Hospital), Thomas Burgoyne(Guy's and St Thomas' NHS Foundation Trust), Andreia Pinto(Guy's and St Thomas' NHS Foundation Trust), Dale Moulding(Great Ormond Street Hospital), Timothy D. McHugh(University College London), Aarash Saleh(Royal Free London NHS Foundation Trust), Eliz Kilich(University College London Hospitals NHS Foundation Trust), Puja Mehta(University College London Hospitals NHS Foundation Trust), Chris O’Callaghan(Great Ormond Street Hospital), Jie Zhou(Imperial College London), Wendy Barclay(Imperial College London), Paolo De Coppi(Great Ormond Street Hospital), Colin R. Butler(Great Ormond Street Hospital for Children NHS Foundation Trust), Mario Cortina‐Borja(Great Ormond Street Hospital), Heloise Vinette(Great Ormond Street Hospital), Sunando Roy(Great Ormond Street Hospital), Judith Breuer(Great Ormond Street Hospital), Rachel C. Chambers(University College London), Wendy Heywood(Great Ormond Street Hospital), Kevin Mills(Great Ormond Street Hospital), Robert E. Hynds(CRUK Lung Cancer Centre of Excellence), Sarah A. Teichmann(University of Cambridge), Kerstin B. Meyer(Wellcome Sanger Institute), Marko Nikolić(University College London Hospitals NHS Foundation Trust), Claire M. Smith(Great Ormond Street Hospital)
Nature Microbiology
April 15, 2024
Cited by 50Open Access
Full Text

Abstract

Children infected with SARS-CoV-2 rarely progress to respiratory failure. However, the risk of mortality in infected people over 85 years of age remains high. Here we investigate differences in the cellular landscape and function of paediatric (<12 years), adult (30-50 years) and older adult (>70 years) ex vivo cultured nasal epithelial cells in response to infection with SARS-CoV-2. We show that cell tropism of SARS-CoV-2, and expression of ACE2 and TMPRSS2 in nasal epithelial cell subtypes, differ between age groups. While ciliated cells are viral replication centres across all age groups, a distinct goblet inflammatory subtype emerges in infected paediatric cultures and shows high expression of interferon-stimulated genes and incomplete viral replication. In contrast, older adult cultures infected with SARS-CoV-2 show a proportional increase in basaloid-like cells, which facilitate viral spread and are associated with altered epithelial repair pathways. We confirm age-specific induction of these cell types by integrating data from in vivo COVID-19 studies and validate that our in vitro model recapitulates early epithelial responses to SARS-CoV-2 infection.


Related Papers

No related papers found

Powered by citation graph analysis